U.S. markets closed

Kontrol Technologies Corp. (KNRLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.4348+0.0648 (+2.73%)
At close: 3:39PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.3700
Open2.3400
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.3400 - 2.6560
52 Week Range1.7440 - 4.7500
Volume7,288
Avg. Volume91,073
Market Cap83.332M
Beta (5Y Monthly)1.25
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • New president at Kaloom™
    CNW Group

    New president at Kaloom™

    MONTREAL, March 8, 2021 /CNW Telbec/ - Laurent Marchand, founding President and CEO of KaloomTM, is pleased to announce that an agreement in principle, subject to various conditions, has been reached on a change of control transaction led by the management of the Company, in partnership with Alternative Capital Group Inc. The change of control transaction is planned to close, if all conditions are met, on April 22nd, 2021.

  • Kontrol to provide BioCloud Field Demonstration and Customer application access
    ACCESSWIRE

    Kontrol to provide BioCloud Field Demonstration and Customer application access

    TORONTO, ON / ACCESSWIRE / February 23, 2021 / Kontrol Technologies Corp. (CSE:KNR) (OTCQB:KNRLF) (FSE:1K8) ("Kontrol Technologies" or "Kontrol" or "Company") is pleased to announce that it plans to provide real-time demonstration of BioCloud units in operation in various customer and/or pilot customer ("customer") applications.

  • Frost & Sullivan Reveals Regional Trends and Cutting-edge Technologies in the Global MRI Market
    CNW Group

    Frost & Sullivan Reveals Regional Trends and Cutting-edge Technologies in the Global MRI Market

    Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global marketSANTA CLARA, Calif. 22, 2021 /CNW/ -- Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in the Global Magnetic Resonance Imaging (MRI) Market, Forecast to 2024, finds that the MRI market is diversifying with momentum in the privatization trend.